Health Care Checkup
February 18, 2022
THE BIG PICTURE
On Thursday, the Senate voted 65 to 27 to approve a House-passed short-term spending bill ahead of the February 18 deadline, when the prior continuing resolution (CR) expired. The CR passed by the Senate will fund the federal government through March 11, which will give Democrats and Republicans additional time to come to an agreement on a larger, long-term omnibus government funding bill. 

On Tuesday, top HHS officials had a conversation with members of Congress to discuss their request for an additional $30 billion to help aid in the fight against COVID-19. HHS is seeking $17.9 billion for COVID-19 vaccines and therapies, $4.9 billion for testing, $3 billion to provide COVID-related care to the uninsured, and $3.7 billion to prepare for future variants. White House Press Secretary Jen Psaki said that the Administration has spent or allocated more than 90% of the American Rescue Plan’s COVID-19 funds.

The Senate voted 50-46 to confirm Robert Califf as the Commissioner of the U.S. Food and Drug Administration (FDA). This will be Califf’s second time leading the agency, as he previously served as the FDA Commissioner during former President Obama's second term. The Republican Senators who voted in his favor were Roy Blunt (MO), Richard Burr (NC), Susan Collins (ME), Lisa Murkowski (AK), Mitt Romney (UT), and Pat Toomey (PA). Democrats and Independents who opposed his confirmation included Bernie Sanders (I-VT), Richard Blumenthal (CT), Maggie Hassan (NH), Ed Markey (MA), and Joe Manchin (WV). Califf faced opposition from these Democrats, in part, due to his close ties to the pharmaceutical industry and the Senators’ concerns regarding the opioid epidemic. Califf tried to ease these concerns, by committing to not taking a position at any drug or medical device company or accept money from them for four years after leaving his role as FDA Commissioner.

The Department of Health and Human Services (HHS) announced that it is making $55 million available to 29 HRSA-funded health centers to help improve access to virtual health care for underserved populations. The virtual care provided by these health centers includes telehealth and remote patient monitoring. The full list of award recipients can be found here.

The Senate Committee on Finance held a hearing on identifying and addressing barriers to care for children and adolescents suffering from mental health problems. The hearing delved into many of the challenges that the mental health workforce faces, including a shortage of workers (especially in rural areas) and inadequate provider reimbursement rates. Members of Congress, and the witnesses at the hearing discussed how important telemental services have been for improving access to care and reducing some of the stigmas associated with mental health disorders. Additionally, the witnesses underscored the importance of providing mental health care to children in schools and recommended that Medicaid update its guidance surrounding behavioral health care provided in schools. MCRT’s summary of the hearing can be found here.

On Thursday, the House Energy and Commerce Subcommittee on Oversight and Investigations held a hearing titled, "Americans in Need: Responding to the National Mental Health Crisis." MCRT’s summary of the hearing can be found here.

President Joe Biden tapped Dr. Alondra Nelson to temporarily be the Director of the White House Office of Science and Technology Policy (OSTP) and Dr. Francis Collins to be the temporary President and Co-Chair of the President’s Council of Advisors on Science and Technology, until “permanent leadership is nominated and confirmed.” Nelson and Collins will help to fill the vacancy left by Eric Lander, who resigned last week due to reports that he bullied and mistreated his coworkers. Nelson currently serves as OSTP’s Deputy Director for Science and Society, and Collins recently stepped down from his long-time role as the director of the National Institutes of Health. More information can be found here.
What to Expect Next Week: Both the House and Senate will be in recess next week. In the Senate, Leader Chuck Schumer (D-NY) teed up a vote on Senator Raphael Warnock's (D-GA) bill (S. 3700), which would require insurers to cap out-of-pocket costs for insulin at $35 per month, for when the Senate returns from recess. Additionally, it is expected that there will be a vote on the Women's Health Protection Act of 2021 (H.R. 3755) when Congress returns to session. Looking ahead to March 1, President Joe Biden is scheduled to give his first State of the Union address.
DEEP DIVE
Biden Administration to Seek an additional $30 Billion in COVID-19 Funding
On Tuesday, top HHS officials had a conversation with members of Congress to discuss their request for an additional $30 billion to help aid in the fight against COVID-19. HHS is seeking $17.9 billion for COVID-19 vaccines and therapies, $4.9 billion for testing, $3 billion to provide COVID-related care to the uninsured, and $3.7 billion to prepare for future variants. Senator Roy Blunt (R-MO), who is the Ranking Member of the health appropriations subcommittee, said that he was involved in Tuesday’s conversation, and said that, “In the categories [HHS is] asking for money, the other money has all been spent or committed to other purposes.” White House Press Secretary Jen Psaki said that the Administration has spent or allocated more than 90% of the American Rescue Plan’s COVID-19 funds.

Robert Califf Confirmed as Commissioner of the FDA
This week, the Senate voted 50-46 to confirm Robert Califf as the Commissioner of the U.S. Food and Drug Administration (FDA). This will be Califf’s second time leading the agency, as he previously served as the FDA Commissioner during former President Obama's second term. The Republican Senators who voted in his favor were Roy Blunt (MO), Richard Burr (NC), Susan Collins (ME), Lisa Murkowski (AK), Mitt Romney (UT), and Pat Toomey (PA). Democrats and Independents who opposed his confirmation included Bernie Sanders (I-VT), Richard Blumenthal (CT), Maggie Hassan (NH), Ed Markey (MA), and Joe Manchin (WV). Califf faced opposition from these Democrats, in part, due to his close ties to the pharmaceutical industry. Califf tried to ease these concerns, by committing to not taking a position at any drug or medical device company or accept money from them for four years after leaving his role as FDA Commissioner.

HHS Makes $55 Million in Funding Available to Improve Access to Virtual Health Care
The Department of Health and Human Services (HHS) announced that it is making $55 million available to 29 HRSA-funded health centers to help improve access to virtual health care for underserved populations. The virtual care provided by these health centers includes telehealth and remote patient monitoring. HHS Secretary Xavier Becerra said that “Virtual care has been a game-changer for patients, especially during the pandemic,” and that “This funding will help health centers leverage the latest technology and innovations to expand access to quality primary care for underserved communities.” The full list of award recipients can be found here.
 
CMS Seeks Feedback on Access to Care and Coverage for Medicaid and CHIP Beneficiaries
On Thursday, the Centers for Medicare and Medicaid Services (CMS) announced that it is seeking stakeholder feedback on the barriers that Medicaid and CHIP enrollees face when trying to access and maintain coverage. CMS is also looking for feedback on challenges beneficiaries face when trying to obtain health care services through Medicaid and CHIP. The RFI is open for a 60-day public comment period, which began on February 17. The RFI can be found here.
 
Senate Finance Committee Holds Part II of its Youth Mental Health Hearing Series
The Senate Committee on Finance held a hearing on identifying and addressing barriers to care for children and adolescents suffering from mental health problems. The hearing delved into many of the challenges that the mental health workforce faces, including a shortage of workers (especially in rural areas) and inadequate provider reimbursement rates. Members of Congress, and the witnesses at the hearing discussed how important telemental services have been for improving access to care and reducing some of the stigmas associated with mental health disorders. Additionally, the witnesses underscored the importance of providing mental health care to children in schools and recommended that Medicaid update its guidance surrounding behavioral health care provided in schools. MCRT’s summary of the hearing can be found here.

President Biden Taps Alondra Nelson and Francis Collins to Temporarily Lead the White House Office of Science and Technology Policy
On Wednesday, President Joe Biden tapped Dr. Alondra Nelson to temporarily be the Director of the White House Office of Science and Technology Policy (OSTP) and Dr. Francis Collins to be the temporary President and Co-Chair of the President’s Council of Advisors on Science and Technology, until “permanent leadership is nominated and confirmed.” Nelson and Collins will help to fill the vacancy left by Eric Lander, who resigned last week due to reports that he bullied and mistreated his coworkers. Nelson currently serves as OSTP9’s Deputy Director for Science and Society, and Collins recently stepped down from his long-time role as the director of the National Institutes of Health. More information can be found here.

VA Proposes Making Changes to the Rating Schedule for Respiratory, Auditory and Mental Disorders
The Department of Veterans Affairs is proposing to make changes to the VA Schedule for respiratory, auditory and mental disorders. These changes include “modernizing the evaluative rating criteria for sleep apnea,” “evaluating tinnitus (ringing in the ears) as a symptom of the underlying disease which causes it,” and “evaluating mental health conditions based on a more robust and holistic approach that assesses how impactful the disability is to cognition.” More information these proposed changes can be found here
SENATE HEARINGS AND EXECUTIVE SESSIONS
N/A
HOUSE HEARINGS AND EXECUTIVE SESSIONS
N/A
ADMINISTRATION ANNOUNCEMENTS
Centers for Medicare & Medicaid Services
 
Food and Drug Administration
 
Guidance Documents from the Centers for Disease Control and Prevention

National Institutes of Health
QUICK LINKS
1341 G Street NW
Washington, DC 20005
202-585-0258